Agrovet Market Animal Health Competitors and Similar CompaniesClear all

Agrovet Market Animal Health's competitors and similar companies include Ophirex, ECO Animal Health Group, Anatara Lifesciences and LLOYD.

	Agrovet Market Animal Health Agrovet Market Animal Health is a company dedicated to the development and export of products for veterinary use.	Ophirex Ophirex is a biotech company that provides oral treatment for snakebite envenoming.	ECO Animal Health Group ECO Animal Health Group is an animal health biotechnology company.	Anatara Lifesciences Anatara Lifesciences is a company developing and commercializing products for gastrointestinal health.	LLOYD LLOYD is a company that manufactures and markets nutritional and pharmaceutical products.
Founding Date	Founding Date 1994	Founding Date 2015	Founding Date 1972	Founding Date 2014	Founding Date 1958
Type	Type Private	Type Private	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development pharma veterinary	Tags Healthcare biotech drug development pharma veterinary	Tags Healthcare biotech drug development pharma veterinary	Tags Healthcare biotech drug development pharma veterinary	Tags Healthcare biotech drug development pharma veterinary
Locations	Locations Cercado de Lima, PE HQ	Locations Corte Madera, US HQ	Locations London, GB HQ Vinhedo, BR Huzhou, CN Dublin, IE Tokyo, JP Santiago De Querétaro, MX Urbandale, US	Locations Carlton, AU HQ	Locations Shenandoah, US HQ
Employees	Employees 2551% increase	Employees 244% decrease	Employees 2241% decrease	Employees N/A	Employees 95
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) £79.6m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods £40.9m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit £39.1m (FY, 2025)	Gross profit $969k (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income N/A	Net income £2.6m (FY, 2025)	Net income ($2m) (FY, 2025)	Net income N/A